News
Regulatory affairsRegulatory Round-up - May 2026
Progress being made in UK regenerative therapies industry says expert reportRegulatory news - May 2016Cell Therapy Manufacturing sign new agreementNew company created to develop novel technology to treat diabetesNew report shows that capacity and capability in cell and gene therapy manufacturing continues to increase in the UKCell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trialCell and Gene Therapy Catapult and Asymptote sign licence agreement for thawing system for cell-based therapiesFrameworks for promising therapies with less mature evidence base to secure adoptionCell and Gene Therapy Catapult appoints three new Non-Executive Directors to the BoardCell Therapy Catapult is now the Cell and Gene Therapy CatapultReNeuron wins major UK grant to advance its exosome nanomedicine platformSynpromics and Cell Therapy Catapult collaborate to develop novel large scale viral vector manufacturing platform based on stable producer cell lines
